Rani Therapeutics GAAP EPS of -$0.04 in-line, revenue of $1.7M beats by $1.2M (NASDAQ:RANI)
· seekingalpha.com
Rani Therapeutics press release (RANI): Q1 GAAP EPS of -$0.04 in-line. Revenue of $1.7M (+900.0% Y/Y) beats by $1.2M. Cash, cash equivalents and marketable secu
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...